Back to XTX Topco Ltd XTX Topco Ltd

TGTX

16 quarters

Position history for XTX Topco LtdXTX Topco Ltd's holdings in TG Therapeutics, Inc.

No. XTX Topco exited its TGTX (TG Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 25,583 shares worth $849,867. XTX Topco first reported TGTX in Q2 2022 and held it in 10 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$157,000

Total Shares Change

-37,019

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$54.94
0
2026-Q1
New
25,583
-
$849,8670.0%$33.22
34
2025-Q4
Exited
0
-100.0%
$00.0%$29.81
0
2025-Q3
New
47,918
-
$1.7M0.1%$36.13
36
2025-Q2
Exited
0
-100.0%
$00.0%$35.99
0
2025-Q1
Increased
39,618
+197.8%
$1.6M0.1%$39.43
41
2024-Q4
New
13,304
-
$400,4500.0%$30.10
33
2024-Q3
Exited
0
-100.0%
$00.0%$23.39
0
2024-Q2
New
22,176
-
$394,5110.0%$17.79
33
2023-Q4
Exited
0
-100.0%
$00.0%$17.08
0
2023-Q3
Increased
19,999
+30.1%
$167,1920.0%$8.36
28
2023-Q2
New
15,376
-
$381,9400.1%$24.84
33
2023-Q1
Exited
0
-100.0%
$00.0%$15.04
0
2022-Q4
Decreased
17,695
-50.6%
$209,3320.0%$11.83
0
2022-Q3
Decreased
35,813
-3.3%
$212,0000.1%$5.92
0
2022-Q2
New
37,019
-
$157,0000.1%$4.25
31

Other major holders of TGTX: BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used